EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma

Xulei Huo, Sihan Ma, Can Wang, Lairong Song, Bohan Yao, Sipeng Zhu, Peiran Li, Liang Wang, Zhen Wu, Ke Wang iD

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Xulei Huo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Chordoma, Skull Base Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skull base chordoma is a rare and aggressive tumour of the bone that has a high likelihood of recurrence. The fundamental differences in single cells between primary and recurrent lesions remain poorly understood, impeding development of effective treatment approaches.

Methods

To obtain an understanding of the differences in single cells between primary and recurrent chordomas, we performed single‐cell RNA sequencing and T‐cell/B‐cell receptor (BCR) sequencing. This allowed us to delineate the differences between the two types of tumour cells, tumour‐infiltrating lymphocytes, myeloid cells, fibroblasts and B cells. Copy number variants (CNVs) were detected and compared between the tumour types to assess heterogeneity. Selected samples were subjected to immunohistochemistry to validate protein expression. Fluorescence in situ hybridisation experiments, Transwell assays and xenograft mouse models helped verify the role of fibronectin 1 (FN1) in chordoma.

Results

Promoting natural killer (NK) cell and CD8_GZMK T‐cell function or inhibiting the transformation of CD8_GZMK T cells to CD8_ZNF683 T cells and promoting the transformation of natural killer T (NKT) cells to NK cells are promising strategies for preventing chordoma recurrence. Additionally, inhibiting the M2‐like activity of tumour‐associated macrophages (TAMs) could be an effective approach. Antigen‐presenting cancer‐associated fibroblasts (apCAFs) and dendritic cells (DCs) with high enrichment of the antigen‐presenting signature were enriched in primary chordomas. There were fewer plasma cells and BCR clonotypes in recurrent chordomas. Remarkably, FN1 was upregulated, had more CNVs, and was more highly secreted by tumours, macrophages, CD4 T cells, CD8 T cells and fibroblasts in recurrent chordoma than in primary chordoma. Finally, FN1 enhanced the invasion and proliferation of chordomas in vivo and in vitro.

Conclusion

Our comprehensive picture of the microenvironment of primary and recurrent chordomas provides deep insights into the mechanisms of chordoma recurrence. FN1 is an important target for chordoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChordomaSkull Base NeoplasmsHead and Neck NeoplasmsHumansAnimalsMiceFibronectinsNeoplasm Recurrence, LocalTreatment OutcomeSkull BaseTumor Microenvironment

Stichwörter der Autor:innen

FN1chordomaimmunosuppressivesingle cell

Substanzen

Fibronectins

Autor:innen und Institutionen

  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Ke Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huo, X., Ma, S., Wang, C., Song, L., Yao, B., Zhu, S., Li, P., Wang, L., Wu, Z., & Wang, K. (2023). Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1429

Vancouver

Huo X, Ma S, Wang C, Song L, Yao B, Zhu S, et al. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1429

BibTeX
@article{Huo2023,
  author = {Huo, Xulei and Ma, Sihan and Wang, Can and Song, Lairong and Yao, Bohan and Zhu, Sipeng and Li, Peiran and Wang, Liang and Wu, Zhen and Wang, Ke},
  title = {Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1429}
}
Kostenlos starten →